Acasti Pharma Shares Up 13% Premarket After Co. Received Composition-Of-Matter Patent From US Patent And Trademark Office For Phoshpolipid Structure of CaPre, Co.'s Lead Candidate For Treatment Of Hypertriglyceridemia